Market Cap 1.43M
Revenue (ttm) 580,000.00
Net Income (ttm) -44.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,679.31%
Debt to Equity Ratio 0.00
Volume 359,085
Avg Vol 12,707,749
Day's Range N/A - N/A
Shares Out 5.41M
Stochastic %K 48%
Beta 4.47
Analysts Hold
Price Target N/A

Company Profile

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. Th...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 798 6700
Address:
1035 Cambridge Street, Suite 18A, Cambridge, United States
Gemola
Gemola Sep. 11 at 5:59 PM
$ERNA Double yesterdays volume! lol
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 11 at 2:36 PM
$ERNA been a long wait, but feel news is next week. 800k milestone warrants are @ $17. They need to pump this big to get the proceeds.
0 · Reply
2pumps1dump
2pumps1dump Sep. 10 at 12:39 PM
$ERNA what happened
1 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 4 at 6:16 PM
$ERNA some comps in the space. We are the "earliest," but organic growth once in the clinic will occur. Just need to be patient. IND news imminent. Current market cap ~ $6 million
1 · Reply
Russell007xx
Russell007xx Sep. 3 at 12:10 PM
$ERNA so when 30? Lol
1 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 2 at 5:03 PM
$ERNA slightest volume or news will send this given the float.
1 · Reply
topstockalerts
topstockalerts Sep. 2 at 1:00 PM
Pre Market Top Gainers PT2 $VIVK $ERNA $UPC $EOSE $DH
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 31 at 2:44 PM
$ERNA maybe we get the IND news this week.
0 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Aug. 31 at 6:13 AM
Holding off on my $BSAA and $ERNA calls from yesterday. I ran my quantitative validation engine overnight to stress-test those setups, and the math revealed a massive "liquidity trap." If you look at the attached image, focus on the bottom line: Info. Coef. = -0.90. In plain English, that is a near-perfect inverse correlation. It means the setups that look the absolute most "perfect" on paper (like BSAA and ERNA) are actually the ones failing the hardest right now. I’m personally shifting my attention down the list to names like $DAIC and $AERT where the structure is still clean, but it isn't carrying that heavy, crowded attention. Thanks
0 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Aug. 30 at 3:01 PM
Just to be clear, my money is on $ERNA for Monday based on the high confidence my model is indicating.
0 · Reply
Latest News on ERNA
Ernexa Therapeutics announces new ERNA-101 preclinical data

2026-07-15T12:15:21.000Z - 1 month ago

Ernexa Therapeutics announces new ERNA-101 preclinical data


Ernexa Therapeutics initiated with a Buy at Brookline

2026-05-07T21:58:10.000Z - 4 months ago

Ernexa Therapeutics initiated with a Buy at Brookline


3 Penny Stocks to Watch Now, 5/7/26

2026-05-07T16:17:11.000Z - 4 months ago

3 Penny Stocks to Watch Now, 5/7/26

AHMA PMAX


Ernexa Therapeutics announces new ERNA-101 preclinical data

2026-05-07T04:27:19.000Z - 4 months ago

Ernexa Therapeutics announces new ERNA-101 preclinical data


Ernexa Therapeutics announces 1-for-25 reverse stock split

2026-04-30T19:19:12.000Z - 4 months ago

Ernexa Therapeutics announces 1-for-25 reverse stock split


Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Apr 30, 2026, 9:00 AM EDT - 4 months ago

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split


Ernexa Therapeutics files $50M mixed securities shelf

2026-03-16T10:56:34.000Z - 6 months ago

Ernexa Therapeutics files $50M mixed securities shelf


Ernexa Therapeutics prices 21M shares at 50c in public offering

2026-02-06T14:30:30.000Z - 7 months ago

Ernexa Therapeutics prices 21M shares at 50c in public offering


Ernexa Therapeutics completes Pre-IND meeting with FDA

2026-01-06T13:38:50.000Z - 8 months ago

Ernexa Therapeutics completes Pre-IND meeting with FDA


Ernexa Therapeutics to Present at Oxford Global's Cell 2025

Nov 11, 2025, 7:00 AM EST - 10 months ago

Ernexa Therapeutics to Present at Oxford Global's Cell 2025


Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split


Ernexa Therapeutics Closes New Funding Round

Apr 3, 2025, 8:55 AM EDT - 1 year ago

Ernexa Therapeutics Closes New Funding Round


Gemola
Gemola Sep. 11 at 5:59 PM
$ERNA Double yesterdays volume! lol
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 11 at 2:36 PM
$ERNA been a long wait, but feel news is next week. 800k milestone warrants are @ $17. They need to pump this big to get the proceeds.
0 · Reply
2pumps1dump
2pumps1dump Sep. 10 at 12:39 PM
$ERNA what happened
1 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 4 at 6:16 PM
$ERNA some comps in the space. We are the "earliest," but organic growth once in the clinic will occur. Just need to be patient. IND news imminent. Current market cap ~ $6 million
1 · Reply
Russell007xx
Russell007xx Sep. 3 at 12:10 PM
$ERNA so when 30? Lol
1 · Reply
SDBiotechInvestor
SDBiotechInvestor Sep. 2 at 5:03 PM
$ERNA slightest volume or news will send this given the float.
1 · Reply
topstockalerts
topstockalerts Sep. 2 at 1:00 PM
Pre Market Top Gainers PT2 $VIVK $ERNA $UPC $EOSE $DH
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 31 at 2:44 PM
$ERNA maybe we get the IND news this week.
0 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Aug. 31 at 6:13 AM
Holding off on my $BSAA and $ERNA calls from yesterday. I ran my quantitative validation engine overnight to stress-test those setups, and the math revealed a massive "liquidity trap." If you look at the attached image, focus on the bottom line: Info. Coef. = -0.90. In plain English, that is a near-perfect inverse correlation. It means the setups that look the absolute most "perfect" on paper (like BSAA and ERNA) are actually the ones failing the hardest right now. I’m personally shifting my attention down the list to names like $DAIC and $AERT where the structure is still clean, but it isn't carrying that heavy, crowded attention. Thanks
0 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Aug. 30 at 3:01 PM
Just to be clear, my money is on $ERNA for Monday based on the high confidence my model is indicating.
0 · Reply
Xen_TorpedoCapital
Xen_TorpedoCapital Aug. 30 at 10:10 AM
Top low float watch for Monday $BJDX (PP) $PAVS (BODN) $ERNA (EXP_X) $BSAA (EXP_Y) $NCEW (CON_Y EAP10D 100%+) PFSA (CON_X EAP10D 100%+)
1 · Reply
Gdori
Gdori Aug. 28 at 10:11 PM
$ERNA Put it on the screen, damn it.
0 · Reply
Gdori
Gdori Aug. 27 at 10:44 PM
$ERNA fuck’s sake, release some news already
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 27 at 4:24 PM
$ERNA could get the IND news as soon as next week. Just too cheap for the MOA + indications they are going into vs. peers.
1 · Reply
VirtualInvestor
VirtualInvestor Aug. 27 at 2:26 PM
$ERNA Participates in the Virtual Investor "Why Now" On-Demand Conference CEO Sanjeev Luther discusses Ernexa's vision for advancing cell therapy and the future of cancer treatment. https://vimeo.com/1221551802/62bd8a407e?fl=ml&fe=ec
1 · Reply
Ernexatx
Ernexatx Aug. 27 at 2:11 PM
$ERNA Participates in the Virtual Investor "Why Now" On-Demand Conference Video now available here: https://virtualinvestorco.com/why-now/ Press Release: https://www.globenewswire.com/news-release/2026/08/27/3352079/0/en/ernexa-therapeutics-participates-in-the-virtual-investor-why-now-on-demand-conference.html
0 · Reply
focafoca99
focafoca99 Aug. 27 at 1:28 PM
$ERNA participated in a virtual "Why Now" on-demand conference highlighting lead cell therapy ERNA-101 and its upcoming Phase 1 trial.
0 · Reply
KiserSose
KiserSose Aug. 25 at 7:04 PM
$ERNA volume is rising, steady rise upwards . With good news this stock detonates..
0 · Reply
kshonstocks
kshonstocks Aug. 25 at 3:33 PM
$ERNA higher highs and on scans
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 25 at 3:26 PM
$ERNA Float is so low this can easily 3-4x on upcoming IND + FIH trial news. Way too cheap compared to other players in the field with very promising preclinical data.
1 · Reply
Gemola
Gemola Aug. 25 at 3:23 PM
$ERNA Weight broke the bridge.
0 · Reply